Atlas Trials

To Investigate the Multiple Dose Safety, Tolerability and Pharmacokinetics of WCK 4282 (FEP-TAZ)

Clinical trial NCT03622008 · COMPLETED

Trial details

NCT number
NCT03622008
Sponsor
Wockhardt
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Antibiotics Causing Adverse Effects in Therapeutic Use
Start date
2018-03-23
Primary completion
2018-05-13
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.